Bubendorf, Switzerland, Monday, March 23, 2015 - CIS Pharma welcomes Davide Panighetti, who reinforces the research team as a new synthesis chemist. Davide’s skills will boost the team working on [...]
Paris, France, Wednesday to Thursday, February 11 to 12, 2015 – CIS Pharma is attending CPhI Worlwide to meet development partners and licensees during the two-day conference in Paris. The [...]
Bubendorf, Switzerland, Monday, January 12, 2015 - CIS Pharma has taken a strategic decision to extend its activity into the field of cancer treatments. The defined objective is to improve [...]
Bubendorf, Switzerland, October 12, 2014 – CIS Pharma signs development and licensing agreement with licensee. Having developed intracameral cefuroxime as a response to the clinical demand for such a product, [...]